Eli Lilly Grows Again in Genetic Medicines, Buying Startup With a New Way to Deliver DNA – MedCity News
Engineered viruses are a mainstay in genetic medicine due to their ability to ferry genetic cargo into cells. But limitations…
Engineered viruses are a mainstay in genetic medicine due to their ability to ferry genetic cargo into cells. But limitations…
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma…
Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this…
Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process. Traditional techniques,…
Michelle Carnahan has spent the better part of the last three decades working in healthcare at companies like Thirty Madison…
Eli Lilly (NYSE:LLY) just pre-announced a $1.57 billion pre-tax charge related to acquired in-process R&D, which is expected to weigh…